MGMT and cervical squamous intraepithelial neoplasia: MGMT promoter methylation appeared as an intermediate event, which is in line with earlier studies showing MGMT promoter methylation in 26% of invasive cancers and 29% of high-grade CIN lesions, compared with only 3% of low-grade CIN lesions (Virmani et al, 2001).